• About
  • Advertise
  • Privacy & Policy
  • Contact
Saturday, November 21, 2026
  • Login
  • Register
thehopper.news
  • Home
    • Home
    • About
    • Editorial Standards
    • Methodology & Sources
  • Briefings
    • Weekly
  • Analysis
  • Regions
    • Africa
    • Americas
    • Asia-Pacific
    • Europe & NATO
    • Middle East & North Africa
    • Russia & Eurasia
  • Themes
    • Energy & Reources
    • Intelligence & Security
    • Economics & Sanctions
    • Foreign Relations & Diplomacy
    • Cyber & Disinformation
  • Video
  • Aggregated
    • RT
    • Opinion
    • News
    • Geopolitics
    • Politics
    • Business
    • World
No Result
View All Result
thehopper.news
No Result
View All Result
Home Aggregated RT

US court greenlights Bayer’s $7.25 bn Roundup cancer deal

by Admin
November 21, 2026
in RT, World
0
US court greenlights Bayer’s $7.25 bn Roundup cancer deal
27
SHARES
108
VIEWS
Share on FacebookShare on Twitter

Published: November 21, 2026 4:33 pm
Author: RT

The ruling could end years of US litigation against Bayer over claims that Roundup weedkiller causes cancer, a legal battle inherited from Monsanto

A US judge has approved a $7.25 billion settlement by German chemical and pharmaceutical giant Bayer over claims that Roundup weedkiller causes cancer. The deal could bring an end to years of costly litigation involving tens of thousands of lawsuits.

Missouri Judge Timothy Boyer granted final approval to the deal on Friday. The nationwide settlement includes people who developed non-Hodgkin lymphoma, a type of blood cancer allegedly linked to Roundup exposure, as well as those who could be diagnosed in the future if they were exposed before February 17, 2026.

Under the deal, Bayer will pay up to $7.25 billion into a compensation fund over 21 years. Individual payouts are expected to average $10,000 to $165,000 depending on the patient’s age, severity of illness, and duration of exposure.

Judge Boyer described the deal as “among the largest in [the] history of mass tort personal-injury class action settlements.” He rejected objections from lawyers who deemed the compensation inadequate, saying further delays could leave seriously ill claimants waiting years for payments. Bayer CEO Bill Anderson welcomed the ruling as “a decisive milestone” in the company’s struggle to mitigate the risks of Roundup litigation.

Read more

FILE PHOTO.
Top US court to review suit against German chemicals giant

Bayer inherited the legal battle when it acquired US agricultural chemical giant Monsanto for $63 billion in 2018. The takeover gave it control of Roundup, one of the world’s most widely used herbicides, but also saddled it with mounting cancer litigation. Bayer currently faces around 65,000 claims in US courts.

Introduced by Monsanto in 1974, Roundup contains glyphosate, a chemical used to kill weeds without harming genetically modified crops designed to resist it. Monsanto was accused of failing to warn users about the alleged cancer risks. Bayer argued that the warnings would violate labeling requirements set by the US Environmental Protection Agency (EPA).

Read more

FILE PHOTO. ©XAMAX / ullstein bild via Getty Images
Court throws out weedkiller maker’s cancer damage appeal

After years of litigation, Bayer reached a preliminary settlement in February. In June, the US Supreme Court restricted lawsuits under state laws requiring additional cancer warnings, paving the way for approval.

The legal battle has already cost Bayer dearly. The company agreed to a $10.9 billion settlement in 2020, has spent at least $14 billion on Roundup litigation, and set aside around $16 billion for related legal costs. Its shares have fallen around 46% since the Monsanto takeover. Despite the ruling on Friday, around 200 cases remain pending in federal courts outside the settlement. The approval could also face appeals, delaying payments and prolonging the dispute.


READ MORE: EU to prolong authorization for controversial herbicide

The controversy over Roundup’s cancer risks remains unresolved. The World Health Organization’s cancer research agency classified glyphosate as ‘probably carcinogenic’ in 2015. While the EPA maintains that glyphosate is unlikely to cause cancer when used as directed, it has been reassessing its health risks since 2022. In September, it expanded the review with the Department of Health and Human Services. Findings are expected next year.

Despite insisting that Roundup is safe, Bayer has removed glyphosate from newer versions sold to US residential consumers, while retaining it in agricultural products.

Full Article

Tags: Russia Today
Share11Tweet7
Previous Post

India to generate over half its electricity from non-fossil sources by 2035 – IEA

Admin

Admin

  • Trending
  • Comments
  • Latest

Paul Mason instigated GCHQ targeting of The Grayzone’s Kit Klarenberg, leaks reveal

March 23, 2026

Trump White House plagiarized Iran war manifesto from Israel-aligned think tank

March 21, 2026

Drugs, sexual blackmail: shocking confession letter exposes Israel’s Red Crescent spy ring

March 26, 2026
Iranian drone intercepted over Dubai UAE March 2026 Operation Epic Fury

The Hopper Daily Brief — March 3, 2026 — Iran Escalates Against Gulf Targets

2
Smoke rising over Manama Bahrain near U.S. Fifth Fleet headquarters following Iranian missile strike February 2026

Bahrain’s Shia Majority Threatens the U.S. Navy’s Most Critical Gulf Command Node

2
Oil tankers idle in Persian Gulf and Trump demands Iran unconditional surrender — week of March 1–7, 2026 Hopper Weekly Brief

The Hopper Weekly Brief — Week 10, March 1-7, 2026

2
US court greenlights Bayer’s $7.25 bn Roundup cancer deal

US court greenlights Bayer’s $7.25 bn Roundup cancer deal

November 21, 2026

India to generate over half its electricity from non-fossil sources by 2035 – IEA

November 21, 2026
Russia’s Northern Sea Route could ‘revolutionize global trade’ – K.J. Noh (VIDEO)

Russia’s Northern Sea Route could ‘revolutionize global trade’ – K.J. Noh (VIDEO)

November 21, 2026
thehopper.news

Copyright © 2023 The Hopper New

Navigate Site

  • About
  • Advertise
  • Privacy & Policy
  • Contact

Follow Us

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
    • Home
    • About
    • Editorial Standards
    • Methodology & Sources
  • Briefings
    • Weekly
  • Analysis
  • Regions
    • Africa
    • Americas
    • Asia-Pacific
    • Europe & NATO
    • Middle East & North Africa
    • Russia & Eurasia
  • Themes
    • Energy & Reources
    • Intelligence & Security
    • Economics & Sanctions
    • Foreign Relations & Diplomacy
    • Cyber & Disinformation
  • Video
  • Aggregated
    • RT
    • Opinion
    • News
    • Geopolitics
    • Politics
    • Business
    • World

Copyright © 2023 The Hopper New

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.